We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+4.67%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$489B
AUM Growth
+$8.01B
Cap. Flow
-$30B
Cap. Flow %
-6.13%
Top 10 Hldgs %
29.25%
Holding
15,615
New
1,894
Increased
5,213
Reduced
6,341
Closed
1,909

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.71B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$613M
3
AAPL icon
Apple
AAPL
+$478M
4
MA icon
Mastercard
MA
+$450M
5
QQQ icon
Invesco QQQ Trust
QQQ
+$424M

Sector Composition

Rank Sector Weight
1 Technology 3.06%
2 Financials 2.32%
3 Consumer Discretionary 2.21%
4 Healthcare 2.2%
5 Communication Services 1.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IFBD icon
13376
Infobird
IFBD
$8.52M
$28K ﹤0.01%
7
-5
-42% -$35.5K
PLX icon
13377
CALL
Protalix BioTherapeutics
PLX
$191M
$28K ﹤0.01%
33,100
-74,700
-69% -$78.2K
SINT icon
13378
SiNtx Technologies
SINT
$10.8M
$28K ﹤0.01%
+2
New +$40.1K
TALK icon
13379
PUT
Talkspace
TALK
$874M
$28K ﹤0.01%
14,000
-2,900
-17% -$8.3K
CSCI
13380
CALL
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$28K ﹤0.01%
782
-411
-34% -$21.6K
PHLT
13381
PUT
DELISTED
Performant Healthcare Inc
PHLT
$28K ﹤0.01%
11,600
-30,700
-73% -$91.4K
ROI
13382
DELISTED
RiskOn International, Inc. Common Stock
ROI
$28K ﹤0.01%
+421
New +$44.7K
LOCL.WS
13383
DELISTED
Local Bounti Corporation Every 13 warrants will be exercisable for one share of common stock at an exercise price of $149.50 per share of common stock
LOCL.WS
$28K ﹤0.01%
+42,722
New +$37.7K
APTO
13384
CALL
DELISTED
Aptose Biosciences, Inc.
APTO
$28K ﹤0.01%
46
-28
-38% -$26.3K
AVX
13385
Avax One Technology Ltd
AVX
$21.7M
0
FTK icon
13386
PUT
Flotek Industries
FTK
$852M
$27K ﹤0.01%
+4,033
New +$22.9K
GTE icon
13387
PUT
Gran Tierra Energy
GTE
$265M
$27K ﹤0.01%
3,510
-13,550
-79% -$110K
SLNO
13388
PUT
DELISTED
Soleno Therapeutics
SLNO
$27K ﹤0.01%
4,420
-1,600
-27% -$16.8K
SURG icon
13389
SurgePays
SURG
$5.48M
$27K ﹤0.01%
+13,584
New +$34.8K
SYBX
13390
DELISTED
Synlogic
SYBX
$27K ﹤0.01%
753
-49
-6% -$1.9K
TRIB
13391
CALL
Trinity Biotech
TRIB
$7.83M
$27K ﹤0.01%
127
-13
-9% -$3.69K
TRIB
13392
Trinity Biotech
TRIB
$7.83M
$27K ﹤0.01%
126
+8
+7% +$2.27K
SLACW
13393
DELISTED
Social Leverage Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
SLACW
$27K ﹤0.01%
32,163
-11,433
-26% -$9.79K
SIOX
13394
PUT
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$27K ﹤0.01%
21,300
+6,100
+40% +$10.8K
IVC
13395
PUT
DELISTED
Invacare Corporation
IVC
$27K ﹤0.01%
10,000
-36,800
-79% -$136K
HIL
13396
PUT
DELISTED
Hill International, Inc. Common Stock
HIL
$27K ﹤0.01%
13,800
+2,100
+18% +$4.33K
PSAGW
13397
DELISTED
Property Solutions Acquisition Corporation II Warrant
PSAGW
$27K ﹤0.01%
48,111
-737
-2% -$541
KLDO
13398
PUT
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$27K ﹤0.01%
11,400
-1,300
-10% -$5.29K
CHNR icon
13399
China Natural Resources
CHNR
$4.55M
$26K ﹤0.01%
1,128
+361
+47% +$14.9K
IMNN icon
13400
CALL
Imunon
IMNN
$6.68M
$26K ﹤0.01%
249
+154
+162% +$24K

Similar funds

Citadel Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Citadel Advisors held 15,615 positions worth $489B, up 1.7% from $481B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Citadel Advisors withdrew a net $30B in Q4 2021, closing 1,909 positions and reducing 6,341 holdings. Its most notable exit was CIMAREX ENERGY CO, an estimated $279M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, up from 3% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Citadel Advisors opened a new position in iShares iBoxx $ High Yield Corporate Bond ETF worth $248M.

  • Citadel Advisors's largest Q4 2021 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,847,920 shares worth $248M.
  • Citadel Advisors added most to Amazon in Q4 2021, an estimated $802M increase.
  • Citadel Advisors's biggest Q4 2021 reduction was Tesla, cutting an estimated $1.71B.
  • Citadel Advisors fully exited CIMAREX ENERGY CO in Q4 2021, selling an estimated $279M.
  • Citadel Advisors's ten largest holdings make up 29% of its $489B portfolio in Q4 2021.
  • Citadel Advisors opened 1,894 new positions and closed 1,909 in Q4 2021.
  • Citadel Advisors's portfolio value rose 1.7% quarter-over-quarter to $489B.

Based on Citadel Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.